Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Current Opinion in Cell Biology|February 28, 2009
Protein kinases as antibacterial targetsMark Schreiber, Ivica Res, Alex MatterPhysical Biology|October 6, 2005
Character and evolution of protein-protein interfacesIvica Res, Olivier LichtargeCancer Biology & Medicine|January 19, 2016
Bridging academic science and clinical research in the search for novel targeted anti-cancer agentsAlex MatterDrug Discovery Today|April 15, 2008
Impact of non-profit organizations on drug discovery: opportunities, gaps, solutionsAlex Matter, Thomas H KellerCurrent Opinion in Pharmacology|July 20, 2002
Protein tyrosine kinase inhibitors: new treatment modalities?Doriano Fabbro, David Parkinson, Alex MatterNature Reviews. Drug Discovery|July 18, 2002
Glivec (STI571, imatinib), a rationally developed, targeted anticancer drugRenaud Capdeville, Elisabeth Buchdunger, Juerg Zimmermann, et al.Heart Failure Reviews|May 9, 2018
Drugs' development in acute heart failure: what went wrong?Vincenzo Teneggi, Nithy Sivakumar, Deborah Chen, et al.Nucleic Acids Research|September 23, 2006
Recovering motifs from biased genomes: application of signal correctionSamiul Hasan, Mark SchreiberBioinformatics (Oxford, England)|May 23, 2002
Compensation for nucleotide bias in a genome by representation as a discrete channel with noiseMark Schreiber, Chris BrownApplied Bioinformatics|May 8, 2004
Detection of signals in mRNAs that influence translationChris M Brown, Grant Jacobs, Peter Stockwell, et al.Pageof 4